D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SCHW
Charles Schwab
SCHW
|
+$602M |
| 2 |
Booking.com
BKNG
|
+$582M |
| 3 |
Walmart Inc
WMT
|
+$407M |
| 4 |
Visa
V
|
+$395M |
| 5 |
Johnson & Johnson
JNJ
|
+$335M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$483M |
| 2 |
Salesforce
CRM
|
+$380M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$364M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$336M |
| 5 |
Colgate-Palmolive
CL
|
+$316M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.47% |
| 2 | Consumer Discretionary | 9.17% |
| 3 | Healthcare | 8.57% |
| 4 | Financials | 7.92% |
| 5 | Industrials | 4.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1826
FS KKR Capital
FSK
$2.96B
| $4.88M | 0.01% |
263,546
-75,379
| -22% | -$1.43M |
|
1827
Tradeweb Markets
TW
$20.8B
| $4.87M | 0.01% |
61,625
-13,949
| -18% | -$1.01M |
|
1828
Watts Water Technologies
WTS
$11.5B
| $4.85M | 0.01% |
28,827
+18,088
| +168% | +$2.98M |
|
1829
Ultragenyx Pharmaceutical
RARE
$2.56B
| $4.85M | 0.01% |
120,888
-169,107
| -58% | -$7.26M |
|
1830
Voyager Therapeutics
VYGR
$189M
| $4.85M | 0.01% |
628,472
-60,228
| -9% | -$479K |
|
|
KVSA
1831
DELISTED
Khosla Ventures Acquisition Co. Class A Common Stock
KVSA
| $4.83M | 0.01% |
476,401
| – | – |
|
1832
Wipro
WIT
$19.3B
| $4.83M | 0.01% |
2,151,122
-1,184,042
| -36% | -$2.82M |
|
1833
New Jersey Resources
NJR
$5.91B
| $4.82M | 0.01% |
+90,638
| New | +$4.62M |
|
1834
PUT
Labcorp
LH
$25.9B
| $4.82M | 0.01% |
24,444
-11,640
| -32% | -$2.4M |
|
1835
PUT
Johnson Controls International
JCI
$87.8B
| $4.82M | 0.01% |
+80,000
| New | +$5.12M |
|
|
OSG
1836
Octave Specialty Group
OSG
$250M
| $4.81M | 0.01% |
310,826
+20,245
| +7% | +$328K |
|
1837
PUT
Teekay Tankers
TNK
$2.68B
| $4.79M | 0.01% |
111,600
-18,400
| -14% | -$683K |
|
1838
PUT
Bio-Rad Laboratories Class A
BIO
$8.74B
| $4.79M | 0.01% |
10,000
-50,000
| -83% | -$23.4M |
|
|
CBAY
1839
DELISTED
Cymabay Therapeutics
CBAY
| $4.79M | 0.01% |
549,044
+280,849
| +105% | +$2.25M |
|
1840
PUT
Las Vegas Sands
LVS
$32.3B
| $4.79M | 0.01% |
83,300
-332,900
| -80% | -$18.6M |
|
1841
PUT
Baxter International
BAX
$13.8B
| $4.78M | 0.01% |
+117,800
| New | +$4.99M |
|
1842
CALL
Bunge Global
BG
$20.4B
| $4.78M | 0.01% |
50,000
-15,900
| -24% | -$1.55M |
|
1843
PUT
Medifast
MED
$110M
| $4.76M | 0.01% |
45,900
+35,900
| +359% | +$3.98M |
|
|
VISN
1844
Vistance Networks Inc
VISN
$2.64B
| $4.76M | 0.01% |
746,678
+648,190
| +658% | +$4.91M |
|
1845
CALL
Skyworks Solutions
SWKS
$9.4B
| $4.74M | 0.01% |
40,200
+32,900
| +451% | +$3.65M |
|
1846
PUT
Agnico Eagle Mines
AEM
$75.4B
| $4.74M | 0.01% |
93,000
-28,100
| -23% | -$1.44M |
|
|
RRAC
1847
DELISTED
Rigel Resource Acquisition Corp.
RRAC
| $4.73M | 0.01% |
452,602
| – | – |
|
|
ALSA
1848
DELISTED
Alpha Star Acquisition Corp
ALSA
| $4.73M | 0.01% |
450,000
| – | – |
|
|
1849
PUT
Bunge Global
BG
$20.4B
| $4.72M | 0.01% |
49,400
-56,700
| -53% | -$5.51M |
|
1850
MakeMyTrip
MMYT
$5.37B
| $4.72M | 0.01% |
192,758
-5,600
| -3% | -$149K |
|
Similar funds
D.E. Shaw & Co's Q1 2023 Portfolio in Review
As of Q1 2023, D.E. Shaw & Co held 5,246 positions worth $93.4B, up 3.2% from $90.5B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
D.E. Shaw & Co withdrew a net $9.17B in Q1 2023, closing 861 positions and reducing 1,787 holdings. Its most notable exit was SVB Financial Group, an estimated $163M position sold in full.
By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 13% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, D.E. Shaw & Co opened a new position in State Street Utilities Select Sector SPDR ETF worth $99.9M.
- D.E. Shaw & Co's largest Q1 2023 buy was State Street Utilities Select Sector SPDR ETF: 2,950,552 shares worth $99.9M.
- D.E. Shaw & Co added most to Charles Schwab in Q1 2023, an estimated $602M increase.
- D.E. Shaw & Co's biggest Q1 2023 reduction was Microsoft, cutting an estimated $483M.
- D.E. Shaw & Co fully exited SVB Financial Group in Q1 2023, selling an estimated $163M.
- D.E. Shaw & Co's ten largest holdings make up 11% of its $93.4B portfolio in Q1 2023.
- D.E. Shaw & Co opened 431 new positions and closed 861 in Q1 2023.
- D.E. Shaw & Co's portfolio value rose 3.2% quarter-over-quarter to $93.4B.
Based on D.E. Shaw & Co's 13F filing for Q1 2023, filed 15 May 2023.